Reorganising Health Care Delivery through a Value-Based Approach Custom Case Solution & Analysis

1. Evidence Brief (Case Researcher)

Financial Metrics

Clinic operating margin: 4.2% (Exhibit 2).
Patient acquisition cost: $450 per new enrollee (Exhibit 3).
Revenue distribution: 70% fee-for-service (FFS), 30% capitated risk-sharing (Exhibit 1).
Clinical outcome variance: 15% delta in chronic disease management costs between top and bottom quartile providers (Paragraph 14).

Operational Facts

Staffing: 1:12 physician-to-patient ratio in primary care units (Paragraph 22).
Technology: Fragmented electronic health records (EHR) across five regional satellite clinics (Exhibit 4).
Geography: Operational footprint spans three states with distinct state-level reimbursement regulations (Paragraph 8).

Stakeholder Positions

Chief Medical Officer: Advocates for centralized data integration to enable outcome tracking (Paragraph 31).
CFO: Prioritizes maintaining FFS volume to ensure immediate cash flow stability (Paragraph 33).
Lead Physicians: Resistant to standardized care pathways, citing professional autonomy (Paragraph 35).

Information Gaps

Patient churn rate by demographic segment.
Specific cost of capital for digital infrastructure investment.
Detailed breakdown of administrative overhead vs. clinical service costs.

2. Strategic Analysis (Strategic Analyst)

Core Strategic Question

How does the organization transition from a volume-based revenue model to a value-based care delivery system without triggering a liquidity crisis?

Structural Analysis

Value Chain Analysis: Primary care acts as the gatekeeper. Current incentives reward volume (FFS) rather than health outcomes. The primary bottleneck is the lack of shared data infrastructure between primary and specialty providers.
Porter Five Forces: High buyer (payer) power due to consolidation in the health insurance sector. Competitive rivalry is intensifying as new entrants offer low-cost, technology-enabled primary care.

Strategic Options

Option 1: Aggressive Pivot to Full Capitation. Move 80% of revenue to risk-sharing within 24 months. Trade-offs: High potential for margin expansion; massive risk of short-term cash flow volatility.
Option 2: Hybrid Incrementalism. Maintain FFS base while creating a dedicated value-based care unit for chronic disease management. Trade-offs: Protects cash flow; risks creating a two-tier internal culture.
Option 3: Strategic Partnership. Outsource chronic care management to a specialized third-party firm. Trade-offs: Rapid deployment; loss of long-term patient relationship control.

Preliminary Recommendation

Option 2 is the preferred path. It allows the organization to build the required analytical capabilities while using the stable FFS revenue to subsidize the transition costs.

3. Implementation Roadmap (Implementation Specialist)

Critical Path

Month 1-3: Standardize EHR data reporting across all clinics.
Month 4-8: Pilot value-based care pathways for diabetes and hypertension.
Month 9-12: Renegotiate payer contracts to include quality-based bonuses.

Key Constraints

Physician Buy-in: The transition fails if the clinical staff views metrics as administrative surveillance rather than clinical tools.
Technical Debt: Current siloed EHR systems prevent real-time performance monitoring.

Risk-Adjusted Implementation

Allocate 15% of the annual budget as a contingency fund for potential revenue dips during the pilot phase. If the pilot fails to show a 5% reduction in total cost of care by month 9, pause expansion and re-evaluate the incentive structure for participating physicians.

4. Executive Review and BLUF (Executive Critic)

BLUF

The transition to value-based care is a survival imperative, not a choice. The current hybrid model is a stop-gap that masks the inefficiency of the FFS revenue stream. The organization must prioritize the integration of clinical data over the protection of current margins. If the firm does not demonstrate superior health outcomes within 18 months, payers will terminate existing contracts. Execution must focus on physician alignment through outcome-linked bonuses rather than top-down mandates.

Dangerous Assumption

The analysis assumes that physicians will change behavior if provided with better data. This ignores the influence of current compensation structures that remain tied to volume, regardless of data availability.

Unaddressed Risks

Regulatory Risk: Changes in federal reimbursement policies could render the value-based care pilot models obsolete.
Talent Flight: High-performing physicians may exit the firm if clinical autonomy is perceived to be diminished by standardized pathways.

Unconsidered Alternative

Divest the underperforming satellite clinics to focus capital and management attention on a single, high-density geographic market to prove the value-based care model at scale before attempting a regional rollout.